Global Grand Challenges: Innovations in Cost-Disruptive Tools for Diagnosis and Screening

This Grand Challenge seeks cost-disruptive tools for diagnosis and screening, defined as devices that amortize capital to near-zero incremental cost and consumable $1-class tests that materially reset the cost curve in LMICs while meeting real-world deployment constraints.

Option A: Smaller proof-of-concept awards

Funding: up to $300,000 total 

Duration: 2 years. 

Option B: Support product refinement and early validation

Funding: $500,000 total 

Duration; 2 years

Option C: Mature platforms or advanced adaptation toward verification and field readiness

Funding: $1,500,000 total 

Duration: 3 years 

Research Authority due date: 21.4.26